Asarpota Rajesh's Form 4 filing
Maravai Lifesciences Holdings, Inc. (MRVI) · filed Aug 3, 2026
- Accession no.
- 0001600301-26-000004
- Filed
- Aug 3, 2026, 4:42 PM ET
- Trade date
- Jul 30, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Asarpota RajeshCIK 0001600301 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 | Class A Common Stock | FTax withholdingDisposed | −5,465 | $6.59 | −$36,014.35 | 428,951 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.